{"eu_number": "EU-1-19-1392", "parse_date": "2022-12-28 18:24:48.102749", "decisions": [{"pdf_file": "EU-1-19-1392_h_dec_0.pdf", "eu_aut_date": "2019-11-11", "eu_brand_name_initial": "Ervebo", "eu_brand_name_current": "Not parsed", "active_substance": "ZEBOV-GP, live)", "eu_nas": true, "eu_atmp": false, "eu_od_initial": "__SCRAPER_NOT_FOUND__", "eu_mah_initial": "Merck Sharp & Dohme B.V.", "eu_aut_type_initial": "conditional", "eu_aut_type_current": "Not parsed"}, {"pdf_file": "EU-1-19-1392_h_dec_1.pdf", "eu_aut_date": "2020-09-15", "eu_brand_name_initial": "Ervebo", "eu_brand_name_current": "Not parsed", "active_substance": "Ebola Zaire Vaccine (rVSV\u2206G-ZEBOV-GP, live)", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "conditional", "eu_mah_current": "Merck Sharp & Dohme B.V."}, {"pdf_file": "EU-1-19-1392_h_dec_2.pdf", "eu_aut_date": "2021-01-14", "eu_brand_name_initial": "Ervebo", "eu_brand_name_current": "Not parsed", "active_substance": "Ebola Zaire Vaccine (rVSV\u2206G-ZEBOV-GP,  live)", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "conditional", "eu_mah_current": "Merck Sharp & Dohme B.V."}, {"pdf_file": "EU-1-19-1392_h_dec_3.pdf", "eu_aut_date": "2022-01-31", "eu_brand_name_initial": "Ervebo", "eu_brand_name_current": "Not parsed", "active_substance": "Ebola Zaire Vaccine (rVSV\u2206G-ZEBOV-GP, live)", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "conditional", "eu_mah_current": "Merck Sharp & Dohme B.V."}], "annexes": [{"pdf_file": "EU-1-19-1392_h_anx_0.pdf", "xml_file": "EU-1-19-1392_h_anx_0.xml", "is_initial": true, "creation_date": "D:20191028090827Z", "modification_date": "D:20191028090827Z", "eu_aut_type_initial": "conditional", "eu_med_type": "small molecule", "eu_indication_initial": "ervebo is indicated for active immunization of individuals 18 years of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus (see sections 4.2, 4.4 and 5.1).\n the use of ervebo should be in accordance with official recommendations.\n"}, {"pdf_file": "EU-1-19-1392_h_anx_1.pdf", "xml_file": "EU-1-19-1392_h_anx_1.xml", "is_initial": false, "creation_date": "D:20200707031957Z", "modification_date": "D:20200707031957Z"}, {"pdf_file": "EU-1-19-1392_h_anx_2.pdf", "xml_file": "EU-1-19-1392_h_anx_2.xml", "is_initial": false, "creation_date": "D:20200818114123Z", "modification_date": "D:20200818114123Z"}, {"pdf_file": "EU-1-19-1392_h_anx_3.pdf", "xml_file": "EU-1-19-1392_h_anx_3.xml", "is_initial": false, "creation_date": "D:20210519100929Z00'00'", "modification_date": "D:20210519060930-04'00'"}], "epars": [{"pdf_file": "EU-1-19-1392_h_public-assessment-report.pdf", "ema_procedure_start_initial": "2019-03-11", "chmp_opinion_date": "2019-10-17", "eu_legal_basis": ["article 8.3"], "eu_prime_initial": "False", "ema_rapp": "bart van der schueren", "ema_corapp": "jan mueller", "ema_reexamination": "False", "eu_accel_assess_g": "True"}], "omars": [], "odwars": []}